Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death
Alida C. Weidenaar(University Medical Center Groningen), Eveline S.J.M. de Bont(Hôpital Saint-Michel), Jessica C.A. Bouma-ter Steege(Beatrix Kinderziekenhuis), Arja ter Elst(University Medical Center Groningen), Jenny Douwes(University Medical Center Groningen), Karel Hählen, Willem A. Kamps(Pediatric Oncology Group), Hendrik J.M. de Jonge(University Medical Center Groningen), V. Fidler, Tiny Meeuwsen-de Boer
Cited by 11
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599